Alteration of vascular urotensin II receptor in mice with apolipoprotein E gene knockout.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Peptides

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.PEPTIDES.2005.08.028PMID 16325305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistochemical investigation of urotensins in the caudal spinal cord of four species of elasmobranchs and the lamprey, Lampetra japonica

  2004cited by this paper
• Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries.

  2004cited by this paper
• Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta.

  2004cited by this paper
• Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy.

  2004cited by this paper
• Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects

  2003cited by this paper
• Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure.

  2003cited by this paper
• The Expression of Urotensin II Receptor (U2R) is Up‐regulated by Interferon‐γ

  2003cited by this paper
• Influence of Interferon-&ggr; on the Extent and Phenotype of Diet-Induced Atherosclerosis in the LDLR-Deficient Mouse

  2003cited by this paper
• Increased plasma urotensin II levels in patients with diabetes mellitus.

  2003cited by this paper
• Effect of chronic hypoxia on contents of urotensin II and its functional receptors in rat myocardium

  2002cited by this paper
• Plasma Urotensin in Human Systolic Heart Failure

  2002cited by this paper
• Antioxidant N-acetylcysteine inhibits vasoactive agents-potentiated mitogenic effect of mildly oxidized LDL on vascular smooth muscle cells.

  2002cited by this paper
• Congestive heart failure and expression of myocardial urotensin II.

  2002cited by this paper
• Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents

  2002cited by this paper
• Lysophosphatidylcholine potentiates the mitogenic effect of various vasoactive compounds on rabbit aortic smooth muscle cells.

  2002cited by this paper
• Stimulating proliferation of aorta smooth muscle cells of rat by rat urotensin II

  2001cited by this paper
• Synergistic Effect of Urotensin II With Mildly Oxidized LDL on DNA Synthesis in Vascular Smooth Muscle Cells

  2001cited by this paper
• Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins.

  2001cited by this paper
• Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation

  2001cited by this paper
• Study on the changes of plasma urotensin II level in coronary atherosclerosis and coronary heart disease after angioplasty

  2001cited by this paper
• The alteration of urotensin-II receptors in rat aorta after balloon angioplasty injury

  2001cited by this paper
• Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation.

  2001cited by this paper
• Differential vasoconstrictor activity of human urotensin‐II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey

  2000cited by this paper
• Contractile responses to human urotensin‐II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat

  2000cited by this paper
• Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction

  1999cited by this paper
• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

  1999cited by this paper
• Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14.

  1999cited by this paper
• Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14).

  1999cited by this paper
• Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

  1998cited by this paper
• Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells.

  1997cited by this paper
• Urotensin II in the central nervous system of the frog Rana ridibunda: immunohistochemical localization and biochemical characterization

  1996cited by this paper
• Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis).

  1994cited by this paper
• Absolute quantification of target DNA: a simple competitive PCR for efficient analysis of multiple samples.

  1993cited by this paper
• Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

  1992cited by this paper
• Functional receptors for fish neuropeptide urotensin II in major rat arteries.

  1988cited by this paper
• Complex effects of Gillichthys urotensin II on rat aortic strips

  1987cited by this paper
• Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes.

  1985cited by this paper

• Pathogenesis of Macrovascular Complications in Diabetes

  2016cites this paper
• Plasma Urotensin II Act as a Diagnostic Biomarker for Acute Coronary Syndromes

  2014cites this paper
• Urotensin II promotes the production of LTC4 in rat aortic adventitial fibroblasts through NF-κB–5-LO pathway by p38 MAPK and ERK activations

  2013cites this paper
• Genetic and Pharmacological Manipulation of Urotensin II Ameliorate the Metabolic and Atherosclerosis Sequalae in Mice

  2012cites this paper
• A closer look at the role of urotensin II in the metabolic syndrome

  2012cites this paper
• Novel pathways and therapies in experimental diabetic

  2012cites this paper
• Novel pathways and therapies in experimental diabetic atherosclerosis

  2012cites this paper
• Osteopontin is involved in urotensin II-induced migration of rat aortic adventitial fibroblasts.

  2011cites this paper
• Urotensin II alters vascular reactivity in animals subjected to volume overload.

  2010cites this paper
• The Pathogenesis of Macrovascular Complications Including Atherosclerosis in Diabetes

  2010cites this paper
• Role of urotensin II in health and disease.

  2010cites this paper
• Human urotensin-II receptor desensitisation

  2009cites this paper
• Elevated expression of urotensin II and its receptor in great artery of type 2 diabetes and its significance.

  2009cites this paper
• Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.

  2009cites this paper
• Urotensin II Receptor Knockout Mice on an ApoE Knockout Background Fed a High-Fat Diet Exhibit an Enhanced Hyperlipidemic and Atherosclerotic Phenotype

  2009cites this paper
• Human urotensin II promotes hypertension and atherosclerotic cardiovascular diseases.

  2009cites this paper
• Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice

  2008cites this paper
• Role of urotensin II in atherosclerotic cardiovascular diseases.

  2008cites this paper
• Urotensin II and atherosclerosis.

  2008cites this paper
• The Urotensin II System in Ischaemic Myocardial Dysfunction.

  2008cites this paper
• Role of urotensin II and its receptor in health and disease

  2007cites this paper
• Urotensin-II in the lung: A matter for vascular remodelling and pulmonary hypertension?

  2007cites this paper
• Human Urotensin II as a Link between Hypertension and Coronary Artery Disease

  2006cites this paper
• The role of urotensin II in cardiovascular and renal physiology and diseases

  2006cites this paper
• Urotensin-II and cardiovascular diseases

  2006cites this paper